Immunology

This COVID-19 roundup discusses the risk of new onset Alzheimer disease, vascular events, and atrial fibrillation after COVID-19 infection, and the impact of vaccination against COVID-19 in individuals on...

In a recent study, researchers examined the relationship between biomarkers, symptom severity, and outcomes for individuals with atopic dermatitis.

This COVID-19 roundup includes coverage of the FDA’s latest emergency use authorization for vaccination in new pediatric populations, the risk of myocarditis following hospitalization, and the duration of...

A recent study examined trends in vaccination rates for human papillomavirus in children within the United States and how they compared with vaccination recommendations.

The American Cancer Society has released an update to its guidelines for human papillomavirus vaccination, based on recommendations released in 2019 by the ACIP.

Researchers analyzed data on more than 23,900 participants with rheumatoid arthritis to determine whether there is an association between time-varying methotrexate use and cardiovascular event risk.

In new data presented at IDWeek 2018, researchers assessed changes in pneumococcal carriage and antibiotic susceptibility in children aged younger than 5 years and HIV-infected adults post-PCV10...

There is currently no approved vaccine for Lassa virus, although it is common around the world and highly prevalent in Africa.

Findings from a new phase 3 trial show the potential of a new IgG4 antibody for the treatment of multidrug-resistant HIV-1.

Consultant360 has put together an overview of trending news in the area of pediatric vaccination.